Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
6.37
-0.14 (-2.15%)
Aug 14, 2025, 2:20 PM - Market open
Evolus Market Cap
Evolus has a market cap or net worth of $412.05 million as of August 14, 2025. Its market cap has decreased by -46.80% in one year.
Market Cap
412.05M
Enterprise Value
507.15M
1-Year Change
-46.80%
Ranking
Category
Stock Price
$6.37
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.32M to $412.05M, an increase of 51.87%. That is a compound annual growth rate of 5.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 421.10M | -39.76% |
| Dec 31, 2024 | 699.07M | 14.94% |
| Dec 29, 2023 | 608.22M | 43.99% |
| Dec 30, 2022 | 422.41M | 16.75% |
| Dec 31, 2021 | 361.81M | 219.06% |
| Dec 31, 2020 | 113.40M | -72.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| Novartis AG | 230.64B |
| AstraZeneca | 229.47B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |